Updates on conventional therapies for inflammatory bowel diseases: 5-aminosalicylates, corticosteroids, immunomodulators, and anti-TNF-α
Jihye Park, Jae Hee Cheon
Korean J Intern Med. 2022;37(5):895-905. Published online 2022 Jul 27 DOI: https://doi.org/10.3904/kjim.2022.132
Citations to this article as recorded by 
Traditional herbal pair Portulacae Herba and Granati Pericarpium alleviates DSS-induced colitis in mice through IL-6/STAT3/SOCS3 pathway
Zhe Cheng, Yi Zhou, Xinyu Xiong, Lingli Li, Zekai Chen, Fan Wu, Ruolan Dong, Qiong Liu, Yan Zhao, Shujun Jiang, Qin Yu, Guang Chen
Phytomedicine.2024; 126: 155283. CrossRef
The impact of 5-aminosalicylates on the efficacy of mesenchymal stem cell therapy in a murine model of ulcerative colitis
Huanhuan Chen, Huimin Wang, XiaoJing Xu, Ya'nan Hu, Jing Su, Dongdong Li, Zimu Li, Shixiang Feng, Jinming Liu, Huanxiang Zhang, Xiaoyan Wang
International Immunopharmacology.2024; 134: 112255. CrossRef
The Impact of Microbiome Interventions on the Progression and Severity of Inflammatory Bowel Disease: A Systematic Review
Malik Kasapoglu, Rajesh Yadavalli, Sarosh Nawaz, Abdulaziz Althwanay, Esraa M AlEdani, Harleen Kaur, Samia Butt
Cureus.2024;[Epub] CrossRef
Marine Algae and Deriving Biomolecules for the Management of Inflammatory Bowel Diseases: Potential Clinical Therapeutics to Decrease Gut Inflammatory and Oxidative Stress Markers?
Alberto Repici, Ahmed Hasan, Anna Paola Capra, Sarah Adriana Scuderi, Irene Paterniti, Michela Campolo, Alessio Ardizzone, Emanuela Esposito
Marine Drugs.2024; 22(8): 336. CrossRef
Aloe-emodin alleviates inflammatory bowel disease in mice by modulating intestinal microbiome homeostasis via the IL-4/IL-13 axis
Dong Yang, Tingrui Ge, Jingyi Zhou, Huazhuan Li, Yonggang Zhang
Heliyon.2024; 10(15): e34932. CrossRef
Natural products targeting Nrf2/ARE signaling pathway in the treatment of inflammatory bowel disease
Botong Li, Yixuan Wang, Xiaolin Jiang, Hongwei Du, Yan Shi, Minghui Xiu, Yongqi Liu, Jianzheng He
Biomedicine & Pharmacotherapy.2023; 164: 114950. CrossRef
Mesalazine-induced esophageal ulcers. a rare adverse effect
Raúl José Díaz Molina, Carlos Comesaña Castellar, Marcelo García Hernández, Carmen Garrido Durán, Marco Antonio Martínez Ortega, Daniel Ginard Vicens
Revista Española de Enfermedades Digestivas.2023;[Epub] CrossRef
Interplay between inflammatory bowel disease therapeutics and the gut microbiome reveals opportunities for novel treatment approaches
Catherine O’Reilly, Susan Mills, Mary C. Rea, Aonghus Lavelle, Subrata Ghosh, Colin Hill, R. Paul Ross
Microbiome Research Reports.2023;[Epub] CrossRef
Microbial Modulation in Inflammatory Bowel Diseases
Jongwook Yu, Jae Hee Cheon
Immune Network.2022;[Epub] CrossRef